Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Pharmedium Services LLC
483
•Pharmedium Services LLC•September 19, 2007

Pharmedium Services LLC – FDA 483, Sep 19, 2007

Record Details

This FDA Form 483 document details observations from an inspection of a firm manufacturing sterile drug products.

**Key Observations:**

* **Sampling and Testing Plan Deficiencies:** The firm's sampling and testing plan for sterility and potency of manufactured sterile drug products lacks assurance that statistical criteria and specifications are met. The sampling volume is not representative of total lots produced. * **Sanitization Procedure Inadequacies:** The procedure for sanitizing supplies and equipment used in sterile drug product manufacturing does not ensure adequate sanitization with a secondary method using a redacted substance. The firm has not evaluated the appropriateness of sanitizing surfaces of redacted bags of redacted drug products. * **Disinfectant Effectiveness Study Deficiencies:** Disinfectant effectiveness studies do not include microbial challenge (microbial recovery) studies to demonstrate the effectiveness of redacted and redacted as sanitizing agents in the interior of Class 100 Laminar Flow Hoods used for sterile drug production. * **Lack of On-going Stability Studies:** The firm does not conduct on-going stability studies for any finished drug products manufactured and distributed, failing to assure the validity of established expiry dates (15, 30, and 45 days). * **Absence of Incoming Material Analytical Testing:** Procedures do not require analytical testing of incoming, commercially available drug products (e.g., Magnesium Sulfate for Injection USP, Cefazolin for Injection USP, Oxytocin for Injection USP, Sterile Vancom

Company
Pharmedium Services LLC
Inspection date
September 19, 2007
Product type
Drugs
Office
Dallas District Office
People
  • Stephen D. Brown (Principal Consultant)
  • Daniel J. Lahar (Cso)
View Company Profile

ID · 8c31b8b5-b0a1-47c9-b709-e37511ecb6ad

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Pharmedium Services LLC
  • 483 - 2010-12-09December 9, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmedium Services LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.